| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 70,182,000 | 56,552,000 | 58,047,000 | 44,184,000 | | Cost of Revenue | 54,613,000 | 40,820,000 | 38,314,000 | 33,700,000 | | | Gross Profit | 15,569,000 | 15,732,000 | 19,733,000 | 10,484,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,425,000 | 5,681,000 | 5,942,000 | 5,152,000 | | Non Recurring | 19,000 | 6,000 | 157,000 | 188,000 | | Others | 2,074,000 | 2,313,000 | 2,547,000 | 2,052,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,051,000 | 7,732,000 | 11,087,000 | 3,092,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (200,000) | 43,000 | 244,000 | (61,000) | | Earnings Before Interest And Taxes | 10,005,000 | 7,756,000 | 7,560,000 | 6,755,000 | | Interest Expense | 210,000 | 207,000 | 236,000 | 391,000 | | Income Before Tax | 9,795,000 | 7,549,000 | 7,324,000 | 6,364,000 | | Income Tax Expense | 4,356,000 | 3,410,000 | 2,953,000 | 2,691,000 | | Minority Interest | (17,000) | (19,000) | (22,000) | (25,000) | | | | Net Income From Continuing Ops | 5,439,000 | 4,139,000 | 4,371,000 | 3,673,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,439,000 | 4,139,000 | 4,371,000 | 3,673,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,439,000 | $4,139,000 | $4,371,000 | $3,673,000 |
|
7.87% Nasdaq 
Income Statement
